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bstract
Eight isolates identified as belonging to the genus Bacillus  were obtained from Aloqt (a crusty dried product made from goat
ilk). The cell-free culture supernatant (CFCS) from the eight isolates possessed an inhibitory spectrum against Staphylococcus
ureus  and Escherichia  coli. The eight unknown bacterial isolates were identified by PCR amplification of their 16S ribosomal RNA
ene and sequencing of the resulting PCR products. All of the isolates were classified as members of Bacillus  amyloliquefaciens,
s their 16S rDNA similarities to the respective species were greater than 99%. The phylogenetic analysis grouped two isolates
ith strain BCRC 11601 and the remaining six isolates with strains MPA 1034 and BCRC 11601. The inhibitory activity of the
FCS was either highly reduced or fully inactivated when treated by proteolytic enzymes, suggesting the possible involvement
f a protein/polypeptide bacteriocin-like inhibitory substance (BLIS) in their antagonism. The optimum growth conditions for
aximum inhibitory activity were achieved at an initial pH of 7, incubation temperature of 37 ◦C, and NaCl concentration of (1%). considerable decrease and/or complete loss of activity occurred at values above and below the optimum. The maximum inhibitory
ctivity occurred after 24 h of incubation; as the incubation time increased, a decrease in the activity was observed until a complete
oss of activity occurred after 72 h of incubation.
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1.  Introduction
With the emergence of bacteria that are resistant to
antibiotics, a marked increase has occurred in the level
of attention given to bacteriocins [1]. These proteins are
considered ideal candidates for food preservation and
personal care applications because the range of their
activity is limited to closely related species, and there-
fore, they would theoretically have no harmful effects on
humans and their normal microbiota [2,3].
Goat milk has a very rich and complex autochthonous
microbiota [4]. The autochthonous microbiota of raw
goat milk is particularly interesting due to its diversity
and the presence of several bacteriocin-producing bacte-
ria [5].
Bacteriocins are ribosomally synthesized proteins
produced during the primary phase of growth by a diverse
group of microorganisms that show bactericidal activity,
usually against closely related species [6]. The known
biological mode of action of bacteriocins is related to
their ability to bind rapidly to anionic liposomes [7].
After bacteriocins interact with anionic lipids, they form
pores in the lipid membrane by interacting with the
peptidoglycan precursor lipid II, thus preventing pep-
tidoglycan biosynthesis and disrupting the lipid bi-layer
organization of the membrane [8].
The majority of recent reports have focussed on
the production by Gram-positive bacteria of antibacte-
rial molecules categorized as bacteriocins [9,10], even
though the majority of Gram-positive bacteria that pro-
duce bacteriocins, and have been described so far, are
related to lactic acid bacteria [11,12]. However, its sen-
sitivity to proteases, its low solubility above pH 6 and
the emergence of resistant strains, indicate the need for
an alternative to Gram-positive bacteria as the producer
organisms [13]. Bacillus  represents an alternative genus
to be investigated for the production of bacteriocins,
including antimicrobial peptides with increased protease
tolerance [9,10,14]. Bacillus  includes many industrial
grade species, some of which have a history of being
safely used in the food industry as probiotics [15,16].
Sequence-based genotyping and inferring phylo-
genetic relations among bacteria have been widely
performed using 16S ribosomal RNA gene sequences
[16]. Bacterial 16S rRNA genes generally contain nine
hypervariable regions flanked by conserved stretches,
which enable PCR amplification when using universal
primers for species identification [17,18].The present study aimed to provide relevant infor-
mation, including the proper identification and the
phylogenic position of the antagonistic Bacillus  spp.
isolated from crusty dried goat milk. Additionally, thersity for Science 10 (2016) 631–641
study aimed to verify the inhibitory spectrum, the nature
of the produced compounds and the optimum growth
conditions for the production of the isolated species.
2.  Materials  and  methods
2.1.  Sample  collection  and  isolation
Eleven Aloqt (traditional crusty dried processed goat
milk) samples were collected from different stores in the
Jeddah area (approximately two samples per store), 10 g
of each Aloqt sample were ground and homogenized
together in 90 ml of sterile normal physiological saline
solution (0.85% NaCl, w/v) and subjected to tenfold
serial dilutions up to 10−9.
One ml of the selected dilutions (>10−4) from each
sample was inoculated into two sets of sterile de
Man, Rogosa and Sharpe (MRS) agar media (DifcoTM,
Detroit, MI, USA). One set was incubated at 37 ◦C in
5% CO2 environment for 48 h, and the other set was
incubated at the same temperature but under anaero-
bic conditions using GasPak (EZTM Gas Generating
Container Systems, BD – Becton, Dickinson and Co.,
Franklin Lakes, NJ, USA). After incubation, the sam-
ples were selected and subjected to Gram staining and
examined under the microscope to allow visualization of
the basic cell characteristics.
Bacterial colonies were further subjected to addi-
tional microbiological analysis for identification by
observing their morphological, physiological and bio-
chemical characteristics as described in previous reports
[19]. The biochemical characteristics were determined
using both API 20E and API 50CH bacterial identifica-
tion test strips (bioMerieux SA, France).
2.2.  Screening  of  isolates  for  antibacterial  activity
Isolates identified as belonging to the genus Bacil-
lus (Gram-positive spore-forming rods) were screened
using two different methods, cross-streak and agar-well
diffusion inhibition assays [20,21], for their antibacterial
activity against two pathogenic organisms (Staphylococ-
cus aureus  and Escherichia  coli), which were obtained
from the King Fahd Hospital in Al-Madina. Rapid
screening for antagonistic isolates was carried out first
by the cross-streak method. Briefly, Müller–Hinton agar
plates (Oxoid Ltd, Basingstoke, Hampshire, UK) were
prepared and inoculated with isolates of the genus Bacil-
lus by a single streak in the center of the Petri dish and
incubated at 37 ◦C for 48 h to provide the active organism
with enough time to produce the antibiotic substance,
which then diffuses into the agar medium. The plates
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ere then seeded with indicator organisms by streaking
erpendicular to the line of the Bacillus  isolate growth.
ntagonism was observed by the end of the incuba-
ion at 37 ◦C for 24 h based on the inhibitory interaction
etween the isolates and the indicator strains.
Based on the cross-streak method results, all isolates
f the genus Bacillus  showing antagonistic activity were
ultured in sterilized Falcon tubes (Sigma–Aldrich, St.
ouis, MO, USA) containing 10 ml of the MRS broth
ith the pH adjusted to ∼6.8 and incubated for 48 h
t 37 ◦C in 5% CO2 environment (until approximately
06 CFU ml−1) to carry out the agar-well diffusion
nhibition assay. After incubation, the bacterial cells
ere removed from the culture by centrifugation for
0 min at 4500 ×  g and 4 ◦C. Cell-free culture super-
atant (CFCS) was harvested and filter-sterilized using
.45 m micro-filters (Acrodisc® 25 mm Syringe Fil-
er w/0.2 m Supor® Membrane, Pall Co., MI, USA)
he obtained (CFCS) was further concentrated into 2-ml
liquots using a rotary evaporator (Rotavapor® R-200,
ÜCHI Labortechnik, Flawil, Switzerland).
The indicator organisms (S.  aureus  and E.  coli) were
rown overnight on nutrient broth (Oxoid Ltd, Bas-
ngstoke, Hampshire, UK) according to their specific
rowth requirements. To create a seeded test media, the
8–24 h culture of the indicator strains was mixed with
terilized Müller–Hinton agar earlier cooled to 45 ◦C at
 final concentration of ∼105 CFU ml−1, poured onto
lates, allowed to solidify, and then dried in a sterile
ood for approximately 2 h prior to use. Sterile Pasteur
ipettes were used to punch 5-mm wells onto the sur-
ace of the Müller–Hinton agar plates seeded with the
ndicator organisms. Then, a micropipette (Eppendorf
iotech, Hamburg, Germany) was used to add 100 l
f each CFCS sample to the wells, where the samples
emained at room temperature for 45–60 min to freely
iffuse. All plates were then incubated overnight at the
ptimal growth temperature (37 ◦C) for the indicator
rganisms. The presence of inhibition halos (clear zones)
round the well was recorded as the antimicrobial activ-
ty of the tested isolate. The well diffusion inhibition
ssays were all conducted in triplicates.
.3.  Molecular  identiﬁcation  of  the  active
ntibacterial  isolates
The identity of the bacterial isolates showing
ntibacterial activity was confirmed using molecular
pproaches. All isolates were cultured overnight in 10 ml
uria–Bertani (LB) broth (DifcoTM, Detroit, MI, USA)
t 37 ◦C for 18 h. After incubation, the cellular DNA
as extracted as previously described by Kageyamarsity for Science 10 (2016) 631–641 633
et al. [22]. Briefly, 2-ml aliquots of the broth culture
were collected in 1.5 ml micro-centrifuge tubes (Eppen-
dorf Biotech, Hamburg, Germany) and centrifuged at
13,000 ×  g for 3 min. The pellet was then suspended
in 200 l TE buffer (10 mM Tris–HCl [pH 8] and
1 mM EDTA), 100 l of lysozyme (20 mg/m), and 10 l
proteinase K (20 mg/ml), and the mixture was incu-
bated for 60 min at 37 ◦C. Afterwards, 250 l GPT
reagent (6 M guanidine thiocyanate dissolved in 50 mM
Tris/HCl, pH 8) and 5 l RNase were added and incu-
bated for 20 min at 65 ◦C. After incubation, 450 l of
Tris-buffered phenol (pH 8) was immediately added,
and the tubes containing the mixture were placed in
a boiling water bath for 15 min; then, 250 l chloro-
form/isoamyl alcohol (24:1, v/v) was added to remove
the excess proteins and lipids. Afterwards, the mixture
was centrifuged for 10 min at 13,000 ×  g. The upper
aqueous phase (∼500 l) was transferred to a fresh tube
and was mixed with an equal amount of 100% ethanol
and a 1/10 volume of 3 M sodium acetate before being
maintained at 20 ◦C for 1 h. Samples were centrifuged at
13,000 ×  g for 15 min at 4 ◦C, and the supernatant was
then discarded. Traces of GPT reagent were removed by
the addition of 500 l ice-cold 70% ethanol to the nucleic
acid pellet, and samples were centrifuged at 13,000 ×  g
again for 5 min at 4 ◦C. The nucleic acid pellet was dried
under a vacuum for 20 min and finally re-suspended in
50 l of sterile nuclease-free TE buffer. Based on the UV
absorbance at specific wavelengths, the molar concentra-
tion and purity of the nucleic acid DNA were determined
using a spectrophotometer (AE-450, ERMA Inc., Tokyo,
Japan). A final concentration of 5 g/ml and purity indi-
cated by an A260/A280 ratio of 1.8–2.1 were considered
acceptable. All reagents used in the extraction of the cel-
lular DNA were obtained from (BDH Chemicals Ltd,
Poole, UK or ACROS Organics, New Jersey, USA).
A nearly complete 16S rRNA gene sequence was
determined for each isolated strain. The 16S rDNA was
amplified by polymerase chain reaction (PCR) using
the prokaryotic 16S rDNA universal primers 8F (5′-
AGAGTTTGATCCTGGCTCAG-3′) forward primer
and 1542R (5′-ACAAAGGAGGTGATC-3′) reverse
primer. The PCR was performed with an automated DNA
thermal cycler (Perkin-Elmer 2720, Applied Biosystems
Inc., USA). The amplification cycle profile was as fol-
lows: an initial denaturation step at 94 ◦C for 5 min; 35
cycles of denaturation at 94 ◦C for 60 s, primer anneal-
ing at 60 ◦C for 60 s, and primer extension at 72 ◦C for
◦120 s; and a final extension step at 72 C for 10 min.
The amplified PCR products were separated on
a 1.5% (w/v) agarose gel (Sigma–Aldrich Chemi-
cal Co., St. Louis, USA) in an electrophoresis cell
h Unive634 A.M. Hanafy et al. / Journal of Taiba
(Wide Mini-Sub Cell GT, Bio-Rad, UK) containing
1× Tris borate EDTA (TBE) buffer (0.09 M Tris,
0.09 M boric acid, and 20 mM EDTA, pH 8) (Gibco®
Life Technologies, NY, USA) at a constant voltage
of 5 V/cm (∼80–100 V) for 45–100 min. After elec-
trophoresis, the agarose gel was stained with 0.5 g/ml
ethidium bromide (Invitrogen Life Technologies, CA,
USA) for 20 min. The DNA bands were visualized
and photographed under UV transillumination in a gel
documentation system (GelDoc 2000, Bio-Rad, UK).
The sizes of the resulting DNA fragments were deter-
mined by comparison with 1 Kb Plus DNA Ladder
standard molecular weight marker (Invitrogen Life Tech-
nologies, CA, USA). Prior to the DNA sequencing,
all PCR products were purified with Silica Spin Col-
umn (Pure-Link PCR Purification Kit, InvitrogenTM,
NY, USA). The PCR products were sequenced by
Macrogen, Inc. (Seoul, Korea). A sequence database
search using the BLAST search program analysis of the
National Center for Biotechnology Information (NCBI,
http://www.ncbi.nlm.nih.gov/BLAST/) against various
sequences was used to identify the phylogenetic sim-
ilarities among the microbially active isolates and the
published DNA sequences in GenBank.
2.4.  Phylogenetic  analysis
Sequence data from the microbially active isolates
were used to construct a phylogenetic tree using the
maximum likelihood method [23]. The statistical sig-
nificance of the tree topology was evaluated using a
bootstrap analysis of the sequence data with clustalW
software [24]. The percentages of the replicate trees in
which the associated taxa clustered together in the boot-
strap test (500 replicates) are shown next to the branches
[25]. Nucleotide substitution rates (Knuc values) were
calculated, and the tree was drawn to scale, with branch
lengths shown in the same units as those of the evo-
lutionary distances used to infer the phylogenetic tree
[26]. The evolutionary history was inferred using the
maximum likelihood method based on the Jukes–Cantor
model [27]. The tree with the highest log likelihood
(−2076.9473) is shown. Initial tree(s) for the heuris-
tic search were obtained automatically by applying the
maximum parsimony method. A discrete gamma distri-
bution was used to model evolutionary rate differences
among sites (five categories (+G, parameter = 0.2891)).
The analysis involved 22 nucleotide sequences. All pos-
itions containing gaps and missing data were eliminated.
A total of 778 positions were included in the final
dataset. Evolutionary analyses were conducted using the
MEGA6 program [28].rsity for Science 10 (2016) 631–641
2.5.  Enzymatic  degradation  to  conﬁrm  the  nature  of
the antimicrobial  compound
The effect of different enzymes (all from
Sigma–Aldrich, Inc., St. Louis, MO, USA) on the
antimicrobial activity was determined [29]. Briefly,
aliquots (100 l) of the CFCS were combined with vari-
ous concentrations of the tested enzymes (0.1–5 mg/ml),
and the mixtures were incubated overnight, with the
pH and temperature adjusted to those optimal for the
enzymatic activity. After 24 h, all samples were used to
repeat another well diffusion inhibition assay against
the indicator organisms.
2.6.  Incubation  time  and  antibacterial  substance
production
To decide the optimal incubation time for the maxi-
mum production of the antibacterial compound, a single
representative isolate was selected, inoculated in MRS
broth medium, and incubated for different time inter-
vals of 12, 24, 48 and 72 h. After incubation, the cell
density was measured at 600 nm using un-inoculated
MRS broth as the blank. Then, the CFCS was harvested
from all batches and used to conduct another well diffu-
sion inhibition assay against the indicator organisms as
previously explained.
2.7.  Growth  conditions  for  antibacterial  substance
production
To determine the optimum pH for the antibacterial
substances production, three sets of 100 ml of MRS broth
were prepared and adjusted to pH 4, 7 and 9, respec-
tively with 6 M HCl or 6 M NaOH stock solutions. The
flasks were inoculated with 18- to 24-hour-old Bacil-
lus amyloliquefaciens  culture and incubated at 37 ◦C for
24 h. After incubation, the CFCS was harvested from all
batches, and the pH of the supernatants was readjusted to
∼6.8 with sterile NaOH to attain the maximum antibac-
terial activity before being used against the indicator
organisms.
To optimize the effect of incubation temperature,
flasks containing 100 ml of sterilized MRS broth with
18- to 24-hour-old B.  amyloliquefaciens  culture were
incubated at 25, 37 and 45 ◦C for 24 h. After incubation,
the CFCS was harvested and used against the indicator
organisms.Sodium chloride (NaCl) salt concentration was opti-
mized by preparing four sets of 100 ml of sterile MRS
broth, with salt concentrations of 1, 2, 4 and 6%, respec-
tively. The flasks were inoculated and incubated at 37 ◦C
A.M. Hanafy et al. / Journal of Taibah University for Science 10 (2016) 631–641 635
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Fig. 1. The effect of the antibacterial substances pro
or 24 h, as previously explained. After incubation, the
FCS was harvested and used in well diffusion inhibition
ssays.
.  Results  and  discussion
.1.  Characterization  of  the  unknown  isolates
A total of 54 bacterial isolates were successfully puri-
ed from the Aloqt using MRS agar plates. Sixty-two
iochemical and physiological tests (API 50CH and 20E
est strips) and a number of morphological characteris-
ics (primarily colony, cell and spore morphology) were
elected and investigated to provide effective differenti-
tion of all isolates. Based on the results of the tests,
ll isolates were identified as belonging to the genus
acillus. Although Aloqt (a type of processed milk)
as purported to contain Lactobacillus  spp., as observed
n other studies [4,5], Bacillus  was the only organism
ecovered from four individual lots of the product in
his study. Similar results showing the isolation of the
enus Bacillus  from fermented milk products presumed
o contain Lactobacillus  spp. was observed in a previ-
us report [30]. Possibly, Lactobacillus  isolates are not
ompetitive with the strains present in the milk prod-
cts. The slow growth of Lactobacillus  strains, along
ith the presence of several microorganisms releasing
etabolic products, may interfere with the metabolism
f the Lactobacillus, thereby leading to the suppressive
ffects [31]. Another explanation is that Lactobacillus
trains often have poor stability during storage; in addi-
ion, the inclusion of flavors, such as essential oils, may
ffect Lactobacillus  bacteria-containing dairy products
ecause of the antagonistic action of the added flavors
gainst several microorganisms [31,32].
Optimal growth conditions for the isolates were
bserved at temperatures between 35 ◦C and 37 ◦C, at
H 7, and under aerobic conditions. No growth occurredtes
y the eight isolates against the indicator organisms.
below 15 ◦C or above 50 ◦C, and no growth occurred
under anaerobic conditions. On solid culture media, the
colonies tended to spread quickly into lawn formation,
with an extremely wrinkled texture and a thick, opaque
slime that was secreted by the colonies. Gram staining
and microscopic examination of each sample of bacterial
growth revealed a Gram-positive, endospore-producing
bacillus. Cells often form chains, and the spores appeared
oval in shape and central, paracentral or sub-terminal in
un-swollen sporangia.
3.2.  Antimicrobial  activity  assay
Eight of the 54 Bacillus  isolates obtained from the
Aloqt possessed potent antibacterial activity in the cross-
streak assay. The well diffusion inhibitory assay revealed
that the antibacterial compounds produced by the eight
isolates exhibited various degrees of inhibitory activi-
ties against both the Gram-positive and Gram-negative
pathogenic bacteria, S.  aureus  and E.  coli, respectively,
indicating that the isolates may have a broad spectrum
of inhibition (Fig. 1). The assay also revealed that all
isolates showed higher antibacterial activity towards
S. aureus  than E.  coli, suggesting that the antibacte-
rial substance produced by the isolates recovered in
this study may be a type of bacteriocin-like inhibitory
substance (BLIS), as bacteriocins produced by Gram-
positive bacteria demonstrate high bactericidal activity
directed principally against other Gram-positive bacte-
ria, whereas Gram-negative bacteria are less sensitive
to the bacteriocins produced by Gram-positive bacteria
[33].
3.3.  Molecular  identiﬁcation  of  the  isolatesAll eight isolates that presented antibacterial activity
against the indicator strains were subjected to molecu-
lar identification using PCR amplification of almost the
636 A.M. Hanafy et al. / Journal of Taibah Unive
Fig. 2. PCR amplification of the 16S rRNA gene from the eight micro-
bially active isolates showing a single gene fragment in the range of
1.5 kb. Lane M: standard DNA molecular weight marker (1 kb plus
DNA ladder), Lanes B1 to B8, the eight isolates.
complete 16S rRNA gene. A single gene fragment was
amplified from each isolate. The size of the generated
fragments was in the range of 1.4–1.5 kb (Fig. 2). PCR
was followed by DNA sequence analysis of the resulting
PCR product. The 16S rDNA nucleotide sequences were
determined for all eight isolates, and a database search
was conducted. Sequencing of the 16S rRNA gene was
sufficient to provide a proper and reliable identification
of the isolates, with variations that allowed differenti-
ation of the species. The BLAST search demonstrated
that these isolates were closely related to B.  amylolique-
faciens, with sequence similarity of more than 99% to
the 16S rRNA gene of B.  amyloliquefaciens, and this was
sufficient to indicate that these eight isolates belong to
the same species. Bacillus  amyloliquefaciens  is closely
related to Bacillus  subtilis  and Bacillus  licheniformis,
and separation of these organisms solely on the basis of
classical tests is not possible [34]. The B.  amylolique-
faciens isolates in our study were easily differentiated
by using the 16S rDNA-based molecular identification
technique.
Few reports exist on bacteriocin synthesis in B.  amy-
loliquefaciens [35]. Recently, B.  amyloliquefaciens  GA1
strains were identified as producers of a novel bacterio-
cin named amylolysin, which has potent antimicrobial
activity towards the food-borne pathogen Listeria  mono-
cytogenes [36] and has been found to be less sensitive
to proteases than other bacteriocins produced by lac-
tic acid bacteria [37]. Interestingly, previous reports
addressing the antibacterial spectrum of bacteriocins iso-
lated from B.  amyloliquefaciens  showed antibacterial
activity against closely related Gram-positive bacteria
only, whereas no inhibition activity was observed against
Gram-negative bacteria, especially E.  coli  [37,38].
However, the bacteriocin-like substance from B.  amy-
loliquefaciens reported in this study showed activity
against both Gram-positive and Gram-negative E.  coli.3.4.  Phylogenetic  afﬁliation  of  the  isolates
The constructed phylogenetic tree using the 16S
rRNA gene sequences of the related members fromrsity for Science 10 (2016) 631–641
Bacillus  (B.  subtilis, B.  licheniformis, B.  tequilensis, B.
cereus, B.  anthracis, B.  thuringiensis, B.  methylotroph-
icus, B.  megaterium  and B.  amyloliquefaciens) revealed
that all eight isolates were grouped with B.  amyloliq-
uefaciens  and are phylogenetically separated from other
Bacillus species (Fig. 3). The phylogenetic tree clearly
shows that the eight isolates could be divided into two
closely related clades, separated by a short branch length,
which indicates a limited number of nucleotide changes.
Two isolates (B3 and B8) comprised one clade that
was closely related to the B.  amyloliquefaciens  strain
BCRC 11601 (GenBank accession NR116022.1). The
remaining six isolates (B1, B2, B4, B5, B6, and B7) made
another clade that was more closely related to strain MPA
1034 (GenBank accession NR117946). These results
were supported by the BLAST search analysis against
published 16S rRNA gene sequences in the GenBank
database (Table 1).
To define the borders of the variable region(s) among
the two divided clades, multiple sequence alignment was
performed using the 16S rRNA gene sequences of the
eight studied isolates, along with B.  amyloliquefaciens
strains MPA 1034 and BCRC 11601. The alignment
results revealed that 16S rRNA gene sequences were
100% identical among isolate B3; isolate B8 with strain
BCRC 11601; and isolates B1, B2, B4, B5, B6, B7 with
strain MPA 1034. The alignment results defined the
variation between the two divided clades as a single
nucleotide polymorphism (SNP) at position 107 (Sup-
plemented Fig. S1). This intra-genomic heterogeneity in
the 16S rRNA gene among the different strains of the
Bacillus spp. has been previously reported [39].
3.5.  Effect  of  enzyme  digestion  on  the  antibacterial
activity
The inhibitory nature of bacterial supernatants may
result from hydrogen peroxide elaborated by the bacteria
[20]. To rule out hydrogen peroxide inhibition culture,
the supernatant was treated with catalase enzyme. After
treatment of the test culture supernatant with catalase, no
change in inhibitory activity of the isolates was observed,
indicating that the active agent is not hydrogen peroxide
being elaborated by the individual isolates.
The nature of the antibacterial substance was con-
firmed by enzymatic assays on the cell-free culture of
the antagonistic isolates (Fig. 4). The antibacterial activ-
ity of the cell-free culture supernatant was not affected
by treatment with lipase, -amylase or lysozyme, which
suggested that the activity of the compound is not
dependent on glycosylation and that no carbohydrates
and lipids are present in its structure. However, the
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 Bacil lus amyloliquefaciens WZZ002 (7021 00433 )
 Bacil lus methylotrophicus (6851 678 45)
 Bacill us amyloliquefaciens (NR0750 05)
 Bacil lus subtili s (691200 518 )
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 Streptomyces griseus (D63872 .1)
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Fig. 3. Likelihood phylogenetic tree based on the nucleotide sequences of the 16S rRNA gene, depicting the phylogenetic relationship between the
eight isolates and other representatives of the Bacillus genera. All sequences were aligned on Streptomyces griseus (GenBank accession D63872.1).
The tree was drawn to scale, with branch lengths measured in the number of substitutions per site. Bootstrap values from 500 replicates.
Table 1
BLAST search results of the studied isolates with the first species on the NCBI including their sequences accession numbers and similarities.
Isolate Name The first species on the BLAST search results GenBank accession # e-Value Identity (%)
B1 Bacillus amyloliquefaciens strain MPA 1034 NR 117946.1 0.0 100
B2 Bacillus amyloliquefaciens strain MPA 1034 NR 117946.1 0.0 100
B3 Bacillus amyloliquefaciens strain BCRC 11601 NR 116022.1 0.0 100
B4 Bacillus amyloliquefaciens strain MPA 1034 NR 117946.1 0.0 100
B5 Bacillus amyloliquefaciens strain MPA 1034 NR 117946.1 0.0 100
B6 Bacillus amyloliquefaciens strain MPA 1034 NR 117946.1 0.0 100
B7 Bacillus amyloliquefaciens strain MPA 1034 NR 117946.1 0.0 100
B8 Bacillus amyloliquefaciens strain BCRC 11601 
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activity was completely lost after the treatment with pro-
teinase K, and similar results have been reported by many
investigators regarding the characterization of the bacte-
riocins [40]. Hence, possibly, the peptide/protein nature
of the molecules is involved in the inhibition. The results
reported herein can be considered as indirect evidence
that the antagonism displayed by the B.  amyloliquefa-
ciens bacterial isolates is mediated by bacteriocin or
bacteriocin-like inhibitory substances (BLIS).In addition, bacteriocins usually have low molecular
weight (rarely over 10 kDa) and can be easily degraded
by proteolytic enzymes, especially by the proteases
of the mammalian gastrointestinal tract [2,41]. This
h University for Science 10 (2016) 631–641
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understanding is in agreement with the observed results
in this study because the activity of the antibacterial com-
pound produced by the tested isolates was significantly
decreased after treatment with other protease enzymes
(pepsin, trypsin and chymotrypsin); thus, these antibac-
terial compounds would not interfere with the intestinal
microbiota and would be safe for human consumption.
3.6.  Effect  of  incubation  time
Representative isolate B1 was selected to test the
effect of incubation time on the antibacterial activity. The
maximum antibacterial compound production occurred
during the early stationary phase (24 h). During the
extended stationary phase of incubation, the activity of
the compound decreased considerably to a complete
cessation of activity (72 h). Although an increase was
observed in the number of cells, no activity was observed
against the indicator isolate after 72 h of incubation
(Fig. 5).
Fig. 6. The effect of different physiological factors on the antibacterial activ
against Staphylococcus aureus (panels A, C and E) and Escherichia coli (panFig. 5. Effect of incubation time on inhibitory activity of the antibacte-
rial compound shown against Staphylococcus aureus, with the increase
in bacterial cell number measured at OD 600 nm.
This decrease in activity, as described by previous
reports, may result from the increase in the concentration
of the BLIS over time, leading to protein aggrega-
tion and adsorption to the cell surface, followed by a
feedback regulation that inhibits the release of more
ity of Bacillus amyloliquefaciens cell-free culture supernatant tested
els B, D and F).
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LIS [42]. Furthermore, because B.  amyloliquefaciens
s responsible for much of the protease enzymes produc-
ion [43], proteolytic degradation of the remaining BLIS
n the culture media will take place by the action of the
ndogenous extracellular proteases induced during this
rowth phase, thereby resulting in the complete loss of
ctivity.
.7.  Optimum  growth  conditions  for  antibacterial
ctivity
Bacteriocins of Gram-positive bacteria have a
oncentration-dependent mode of action, which is
ffected by the various physiological factors that affect
ell growth, such as pH, temperature and salt concen-
ration; all of these factors seem to affect bacteriocin
roduction, as well as its activity [44].
The highest antibacterial activity for all isolates
gainst indicator strains was recorded in MRS broth with
n adjusted pH of 7, a salt concentration of 1%, and an
ncubation temperature of 37 ◦C (Fig. 6). A considerable
ecrease was observed in the antibacterial activity of the
solates, but the antibacterial activity remained relatively
table against both indicator strains after incubation at
H 11. These findings are in agreement with previous
eports of considerable inactivation of bacteriocin action
t pH values above 9 [45]. The results also show that the
ntibacterial activity of the isolates survived incubation
t acidic (pH 4) pH levels, suggesting that the producing
solates have some acid-tolerance mechanism that sup-
orts their BLIS production even under extremely acidic
onditions.
The optimum temperature for the production of the
ntibacterial compound was 37 ◦C, indicating that the
ptimum temperatures for production and growth are
orrelated. A significant reduction in the antibacterial
ctivity among all isolates against the indicator strains
as observed on incubation at 45 ◦C; by contrast, the
eduction in the antibacterial activity observed on incu-
ation at 25 ◦C was minimal (Fig. 6). Similar findings
ere also recorded in previous research [46].
The data indicate that the antibacterial activity of the
solates survived salt concentrations up to 4%, which
llows the hypothesis that salt-tolerance mechanisms
xist in the produced isolates, which helps maintain the
smolarity of the cell.
The antibacterial activity was observed against S.
ureus at all of the tested NaCl concentrations (1–6%,
/v), but in the case of E.  coli, a complete loss of antibac-
erial activity against Escherichia  coli  occurred when the
% (w/v) NaCl concentration was used (Fig. 6). Proba-
ly, the bacterial metabolism is sensitive to salt, as saltrsity for Science 10 (2016) 631–641 639
exhibits specific ionic and water binding properties [47];
thus, the addition of salt leads to a decrease in the water
activity (aw). A decrease in aw below the optimum val-
ues for growth often result in a linear decrease of the
growth rate and, thus, in the production of the antibacte-
rial compound [48,49].
Although, all of the antagonistic isolates in this study
belonged to the same species, the antibacterial com-
pound produced by them showed a wide range of activity
against the indicator strains (Figs. 1 and 6). This result
was in agreement with a previous report regarding BLIS
produced by B.  amyloliquefaciens  isolates [50], and
based on the bacteriocin concentration-dependent mode
of action theory, the difference in the susceptibility pat-
terns of the test strains could be due to differences in
the amounts of inhibitory substance produced among the
isolates.
Overall, the results definitely suggest that the
active component of the producer isolates could be an
antibacterial molecule of bacteriocin-like inhibitory
substances. Such data can justify further studies with the
purified compound to confirm their role as a bacteriocin,
as well as their potential to be employed in different
applications.
4.  Conclusion
According to the results collected during the above-
described survey, the antibacterial activity of the isolates
was properly characterized and verified. These antag-
onistic isolates possessed an inhibitory effect against
both Gram-positive and Gram-negative indicator orga-
nisms (S.  aureus  and E.  coli, respectively) and thus
may represent a potential source for the production of
a wide inhibitory spectrum antibiotic. The molecular
approaches used in this study were successfully able
to identify all of the isolates as B.  amyloliquefaciens
and reveal the intra-genomic heterogeneity in their 16S
ribosomal RNA genes, which classified them as two dif-
ferent strains: BCRC 11601 and MPA 1034. Finally, the
nature of the produced compound, along with the opti-
mum growth conditions for its maximum production,
was established, and indirectly, the compound has been
proven to be a type of bacteriocin or bacteriocin-like
inhibitory substance (BLIS). These findings open sev-
eral perspectives for further investigation and prompt
new interest in antimicrobial substances produced by B.
amyloliquefaciens  bacteria.
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